Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The seventh pathogenic fusion gene FIP1L1-RARA was isolated from a t(4;17)-positive acute promyelocytic leukemia

4 Jul 2008

Abstract excerpt

The majority of acute promyelocytic leukemia (APL) cases are characterized by the expression of the chimeric fusion gene PML-RARA . Although the PML-RARA fusion gene is detected in more than 95% of APL cases, RARA has also been found to fuse with other partner genes in some APL variants. To date,

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Eosinophilic Disorders and Syndromes
Share to Retinoids in leukemia and cellular processes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18603554
DOI: 10.3324/haematol.12854

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The seventh pathogenic fusion gene FIP1L1-RARA was isolated from a t(4;17)-positive acute promyelocytic leukemiaPMID 18603554Read ↗

Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion GeneSemantic proximity Read ↗

Classic and Variants APLs, as Viewed from a Therapy ResponseSemantic proximity Read ↗

Current views on the genetic landscape and management of variant acute promyelocytic leukemiaSemantic proximity Read ↗

<i><scp>GTF</scp>2I‐<scp>RARA</scp></i> is a novel fusion transcript in a t(7;17) variant of acute promyelocytic leukaemia with clinical resistance to retinoic acidSemantic proximity Read ↗

Critical role of tripartite fusion and LBD truncation in certain RARA- and all RARG-related atypical APLSemantic proximity Read ↗

Uncovering the <em>PML::RARA </em>Fusion in Cytogenetically Cryptic and FISH-Negative Acute Promyelocytic Leukemia - A Case Report and Comprehensive Literature ReviewSemantic proximity Read ↗

Identification of the STAT5B-RARα fusion transcript in an acute promyelocytic leukemia patient without FLT3, NPM1, c-Kit and C/EBPα mutation.Semantic proximity Read ↗

Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic LeukemiaSemantic proximity Read ↗

A novel NPM1-RARG-NPM1 chimeric fusion in acute myeloid leukaemia resembling acute promyelocytic leukaemia but resistant to all-trans retinoic acid and arsenic trioxideSemantic proximity Read ↗

The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemiaSemantic proximity Read ↗

Identification of a Novel Fusion Gene,<i>IRF2BP2-RARA</i>, in Acute Promyelocytic LeukemiaSemantic proximity Read ↗

BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.